Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2009
07/16/2009CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/15/2009EP2078013A1 Novel crystalline modification of 4- (n-methyl-2-chloro-5-pyridylmethylamino) -2,5-dihydrofuran-2-one
07/15/2009EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
07/15/2009EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/15/2009EP2077997A1 Pyridazine derivatives
07/15/2009EP2077841A1 Novel substituted pyrimidines as cysteine protease inhibitors
07/15/2009EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
07/15/2009EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
07/15/2009CN101484446A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds
07/15/2009CN101484445A An enantioselective synthesis of pyrrolidine-substituted flavones
07/15/2009CN100513407C Tricyclic delta-opioid modulators
07/15/2009CN100513397C Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
07/15/2009CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof
07/14/2009US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
07/14/2009US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid
07/14/2009US7560563 Process for producing 2-substituted pyridine derivative
07/14/2009US7560554 fac-Bis[2-(2-pyridinyl- kappa N)phenyl- kappa C]-[2-(2-pyridinyl- kappa N)(5-formylphenyl)- kappa C]-iridium(III); phosphorescence emitters; organic light-emitting diode, an organic integrated circuit, an organic field effect transistor, an organic thin-film transistor, an organic solar cell
07/14/2009US7560546 Tyrosine kinase inhibitors
07/14/2009US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments
07/14/2009US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors
07/14/2009US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
07/14/2009US7560464 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/14/2009US7560462 Compounds useful for inhibiting CHK1
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/14/2009US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
07/14/2009US7560435 Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine)
07/14/2009US7560124 Photochromic compounds
07/14/2009CA2533369C Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
07/14/2009CA2403321C Amide compounds and use thereof
07/10/2009WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/10/2009CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/09/2009WO2009086041A1 Herbicidal pyridazinone derivatives
07/09/2009WO2009085584A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
07/09/2009WO2009085344A2 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
07/09/2009WO2009084773A2 Preparation process useful in synthesis of atorvastatin
07/09/2009WO2009084695A1 2-aminoquinazoline derivative
07/09/2009WO2009084655A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T
07/09/2009WO2009083581A1 Carboxamide compounds and their use as calpain inhibitors
07/09/2009WO2009083553A1 Azine compounds as glucokinase activators
07/09/2009WO2009083526A1 Novel compounds
07/09/2009WO2009062874A3 Benzimidazole derivatives and their use as fxr agonists
07/09/2009US20090176989 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
07/09/2009US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
07/09/2009US20090176973 Thrombopoietin mimetics
07/09/2009US20090176859 Cathepsin cysteine protease inhibitors
07/09/2009US20090176856 Muscarinic receptor antagonists
07/09/2009US20090176854 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance
07/09/2009US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
07/09/2009US20090176837 Compounds with activity at retinoic acid receptors
07/09/2009US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins
07/09/2009US20090176828 treating pain with minimal cardiovascular and/or sedatory activity side effects;hypertension, depression, glaucoma, elevated intraocular pressure, ischemic neuropathies, optic neuropathy, diabetic retinopathy, stroke, withdrawal symptoms, obsessive compulsive disorder, obesity, diarrhea, nasal congestion
07/09/2009US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
07/09/2009US20090176799 Phosphodiesterase 4 inhibitors
07/09/2009US20090176793 3-(l,3-BENZODIOXOL-5-YL)-6-(4-CYCLOPROPYLPIPERAZIN-l-YL)-PYRIDAZINE, ITS SALTS AND SOLVATES AND ITS USE AS HISTAMINE H3 RECEPTOR ANTAGONIST
07/09/2009US20090176780 Nitrogenous heterocyclic compounds
07/09/2009US20090176774 Compounds and methods of use
07/09/2009US20090176771 Gyrase inhibitors and uses thereof
07/09/2009US20090176767 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
07/09/2009US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
07/09/2009US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis
07/09/2009US20090176730 N4-acylcytosine nucleosides for treatment of viral infections
07/09/2009US20090176307 Compounds, Compositions and Methods
07/09/2009US20090176279 Bioreactive agents
07/09/2009US20090175888 Methods of treating cancer with an antibody-drug conjugate
07/09/2009US20090174312 Tetraphenylnaphalene Derivatives and Organic Light Emitting Diode Using the Same
07/09/2009CA2710903A1 Carboxamide compounds and their use as calpain inhibitors
07/09/2009CA2707520A1 Herbicidal pyridazinone derivatives
07/08/2009EP2077265A1 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof
07/08/2009EP2076504A2 Dichroic-photochromic compounds and devices
07/08/2009EP2076503A2 C-phenyl glycitol compound for the treatment of diabetes
07/08/2009EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
07/08/2009EP2076495A1 Quinoline derivatives with 5-ht-binding properties
07/08/2009EP2076260A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
07/08/2009EP2076128A2 Protein kinase inhibitors and methods for using thereof
07/08/2009EP1592686B1 Gyrase inhibitors and uses thereof
07/08/2009CN101479260A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509807C Indazole derivative for pestide
07/08/2009CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
07/08/2009CN100509804C N-substituted piperidine derivatives as serotonin receptor agents
07/08/2009CN100509803C Extractive of total benzofuran of benzoin plants, prepn. method and use thereof
07/08/2009CN100509801C HIV inhibiting pyrimidines derivatives
07/08/2009CN100509794C Therapeutic heterocyclic compounds
07/08/2009CN100509791C Compound and use of the compound as glycine transport inhibitors
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/07/2009US7557210 Antiinflamamtory agents
07/07/2009US7557208 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism
07/07/2009US7557137 Gamma-lactams as beta-secretase inhibitors
07/07/2009US7557130 Bicyclic heteroaromatic alanines
07/07/2009US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557124 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
07/07/2009US7556797 Absorption, fluorescence of light; diagnosis of kidney, heart diseases
07/07/2009CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
07/07/2009CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
07/07/2009CA2450033C Viral polymerase inhibitors
07/07/2009CA2378834C Pyrazinones, compositions containing such compounds
07/02/2009WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation